Literature DB >> 18499775

Children admitted with acute wheeze/asthma during November 1998-2005: a national UK audit.

G Davies1, J Y Paton, S J Beaton, D Young, W Lenney.   

Abstract

OBJECTIVE: To report 8 years' data from a UK-wide audit of acute wheeze/asthma management in children carried out annually since 1998.
DESIGN: Paediatricians were invited to complete a simple form based on British Thoracic Society (BTS) asthma guidelines for any child over 1 year of age admitted with acute wheeze/asthma each November from 1998 to 2005. Information was collected about patient demographics, initial hospital severity assessment, in-hospital treatment, asthma education and emergency planning, discharge treatment and follow-up.
RESULTS: Data on 9429 admissions were available, with between 53 and 67 centres participating each year. The majority of children were under 5 years of age (median age 3 years). Nearly all were treated with bronchodilators, and around 90% received systemic steroids. Vital signs (pulse and respiratory rate) and oxygen saturation on admission remained stable over the audit period. However, the proportion of admitted children given bronchodilators exclusively by spacer increased from 7% to 44% between 1998 and 2005. The proportion discharged with written asthma plans increased from 24% to 41%. Wide variations were noted between centres in the proportions of children receiving chest x rays and written asthma plans. Children admitted under the care of a respiratory specialist were more likely to have documentation that they had been given written asthma information and a written asthma plan and had had their inhaler device technique checked than if under the care of a general paediatrician.
CONCLUSIONS: In many areas, hospital treatment closely followed published guidance. However, some important deficiencies were noted and variations remain. As well as monitoring guideline implementation, national audit can highlight opportunities for research and improving care locally and nationally.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499775     DOI: 10.1136/adc.2007.133868

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

Review 1.  Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.

Authors:  Malcolm Brodlie; Atul Gupta; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Francine M Ducharme; Michael C McKean
Journal:  Cochrane Database Syst Rev       Date:  2015-10-19

2.  Patient reported outcomes for preschool children with recurrent wheeze.

Authors:  Makrinioti Heidi; Keating Emily; Holden Benjamin; Coren Michael; Klaber Robert; Blair Mitch; Griffiths Chris; Watson Mando; Bush Andrew
Journal:  NPJ Prim Care Respir Med       Date:  2019-03-26       Impact factor: 2.871

3.  Implementation of a Children's Safe Asthma Discharge Care Pathway Reduces the Risk of Future Asthma Attacks in Children-A Retrospective Quality Improvement Report.

Authors:  Lesley Kennedy; Gillian Gallagher; Barbara Maxwell; Brigitte Bartholme; Andrew Fitzsimons; Catherine Russell; Orla Mallon; Jenny L Hughes; Susan Beattie; Veena Vasi; Dara Bartholomew O'Donoghue; Michael David Shields
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

4.  Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.

Authors:  Chinedu Nwokoro; Hitesh Pandya; Stephen Turner; Sandra Eldridge; Christopher J Griffiths; Tom Vulliamy; David Price; Marek Sanak; John W Holloway; Rossa Brugha; Lee Koh; Iain Dickson; Clare Rutterford; Jonathan Grigg
Journal:  Lancet Respir Med       Date:  2014-09-08       Impact factor: 30.700

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.